NCT01904955

Brief Summary

The results of this study will make it possible, thanks to better understanding of the natural history of colorectal cancer, to define new treatment and surveillance strategies for colorectal cancers resected with curative intent, so as to improve management and thus improve patient survival. These data will also make it possible to calculate the prevalence of patients who require treatment or surveillance because of their disease.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
598

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2010

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2013

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 8, 2013

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 22, 2013

Completed
Last Updated

March 12, 2026

Status Verified

March 1, 2026

Enrollment Period

2.4 years

First QC Date

July 8, 2013

Last Update Submit

March 10, 2026

Conditions

Colorectal Cancer

Outcome Measures

Primary Outcomes (1)

  • data concerning evolving relapse

    * the date of recurrence * the site * the finality of the surgical treatment (resection with curative intent defined as macroscopically complete resection, without involvement of the surgical margin in the histological examination) * the non-surgical adjuvant or palliative treatments (radiotherapy, chemotherapy).

    during the 10 years following resection for colorectal cancer with curative intent

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients with adenocarcinoma of the colon or rectum

You may qualify if:

  • with adenocarcinoma of the colon or rectum (ICD-O: C18, C19 and C20)
  • residing in the département of Côte-d'Or (501,000 inhabitants according to the 1999 census) or Calvados (511, 012 inhabitants) at the moment of diagnosis
  • recorded by either Registry between January 1985 and December 2000
  • treated by resection with a curative intent.

You may not qualify if:

  • Will be excluded other morphologic tumours and initially metastatic colorectal cancers, anal cancers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Dijon

Dijon, 21079, France

Location

Related Publications (1)

  • Cottet V, Bouvier V, Rollot F, Jooste V, Bedenne L, Faivre J, Launoy G, Bouvier AM. Incidence and patterns of late recurrences in rectal cancer patients. Ann Surg Oncol. 2015 Feb;22(2):520-7. doi: 10.1245/s10434-014-3990-1. Epub 2014 Aug 27.

    PMID: 25160733RESULT

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • FAIVRE Jean

    CHU Dijon Gastroentérologie

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2013

First Posted

July 22, 2013

Study Start

September 1, 2010

Primary Completion

February 1, 2013

Last Updated

March 12, 2026

Record last verified: 2026-03

Locations

FR(1)